These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 31311566)

  • 1. Super-enhancers: critical roles and therapeutic targets in hematologic malignancies.
    Jia Y; Chng WJ; Zhou J
    J Hematol Oncol; 2019 Jul; 12(1):77. PubMed ID: 31311566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Super-Enhancers Dysregulations in Hematological Malignancies.
    Belloucif Y; Lobry C
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
    Chen X; Ma Q; Shang Z; Niu Y
    NPJ Precis Oncol; 2020 Nov; 4(1):31. PubMed ID: 33299103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
    Dębek S; Juszczyński P
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
    Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
    Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting complexes of super-enhancers is a promising strategy for cancer therapy.
    Zheng C; Liu M; Fan H
    Oncol Lett; 2020 Sep; 20(3):2557-2566. PubMed ID: 32782573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
    Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of super enhancer in cancer].
    Wu ZQ; Mi ZY
    Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
    Jia Q; Chen S; Tan Y; Li Y; Tang F
    Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment.
    He Y; Long W; Liu Q
    Front Pharmacol; 2019; 10():361. PubMed ID: 31105558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super-enhancers complexes zoom in transcription in cancer.
    Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
    J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advance in the research on super-enhancer.
    Sun CB; Zhang X
    Yi Chuan; 2016 Dec; 38(12):1056-1068. PubMed ID: 28034838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma.
    Zhou J; Toh SH; Tan TK; Balan K; Lim JQ; Tan TZ; Xiong S; Jia Y; Ng SB; Peng Y; Jeyasekharan AD; Fan S; Lim ST; Ong CJ; Ong CK; Sanda T; Chng WJ
    Mol Cancer; 2023 Apr; 22(1):69. PubMed ID: 37032358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-enhancers and novel therapeutic targets in colorectal cancer.
    Liu Q; Guo L; Lou Z; Xiang X; Shao J
    Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-enhancers: A new frontier for glioma treatment.
    Cheng M; Zhang ZW; Ji XH; Xu Y; Bian E; Zhao B
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188353. PubMed ID: 32112817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super enhancer lncRNAs: a novel hallmark in cancer.
    Song P; Han R; Yang F
    Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting super enhancers for liver disease: a review.
    Yang Z; Liu Y; Cheng Q; Chen T
    PeerJ; 2023; 11():e14780. PubMed ID: 36726725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.
    Liu S; Dai W; Jin B; Jiang F; Huang H; Hou W; Lan J; Jin Y; Peng W; Pan J
    Mol Cancer; 2024 Jun; 23(1):122. PubMed ID: 38844984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions and Clinical Significance of Super-Enhancers in Bone-Related Diseases.
    Qu J; Ouyang Z; Wu W; Li G; Wang J; Lu Q; Li Z
    Front Cell Dev Biol; 2020; 8():534. PubMed ID: 32714929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.